Author

V. Lotteau

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

P.-O. Vidalain· 2 shared A. Amara· 1 shared A. Aublin-Gex· 1 shared A. Labeau· 1 shared A. Lefevre-Utile· 1 shared B. Panthu· 1 shared C. Jacquemin· 1 shared F. V. Filipp· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

P.-O. Vidalain

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Characterization and functional interrogation of SARS-CoV-2 RNA interactome

A. Labeau, A. Lefevre-Utile, L. Bonnet-Madin, L. Fery-Simonian, V. Soumelis, V. Lotteau, P.-O. Vidalain, A. Amara, L. Meertens

This study identifies 142 RNA-binding proteins interacting with SARS-CoV-2 RNA and finds many are proviral, offering potential drug targets for antiviral therapies.

bioRxiv · Mar 23, 2021Microbiology

Lipogenesis and innate immunity in hepatocellular carcinoma cells reprogrammed by an isoenzyme switch of hexokinases

L. Perrin-Cocon, P.-O. Vidalain, C. Jacquemin, A. Aublin-Gex, K. Olmstead, B. Panthu, G. J. P. Rautureau, P. Andre, P. Nyczka, M.-T. Hutt, N. Amoedo, R. Rossignol, F. V. Filipp, V. Lotteau, O. Diaz

This study shows that switching hexokinase isoenzymes in HCC cells alters metabolism and reactivates innate immunity, improving survival outcomes.

bioRxiv · Mar 13, 2020 · PreprintCancer Biology